why PrIME's cGMP approval not inform shareholders, page-11

Grogger,
I agree with Tooheys8.
With great respect I say to you it is nonsense to suggest it is the same old same old. A bit of basic research into our current leader will quickly throw up a chalk and cheese comparison with the previous regime....that is if we want to talk in platitudes.
In regard to this last debt, did you consider that now with the passage of time the creditor will also have recourse.... the ability to recover from the other mob. We are told they are pouring millions into PrIME so why wouldn't they go after them to recover what after all is really their debt?
Patience is always a virtue and necessity with bio stocks and in this instance I agree that no news is good news.
GLTA
Kind regards,